Prevalence and predictors of inappropriate apixaban dosing in patients with non-valvular atrial fibrillation at a large tertiary academic medical institution

HA Badreldin, L Alreshoud, R Altoukhi… - Drugs & Therapy …, 2020 - Springer
Objectives The aim of this study was to assess apixaban prescribing practices for stroke
prevention in patients with non-valvular atrial fibrillation (NVAF), and to examine the factors …

Prevalence and predictors of inappropriate apixaban dosing in patients with non‑valvular atrial fibrillation at a large tertiary academic medical institution

HA Badreldin, L Alreshoud, R Altoukhi… - Drugs & Therapy …, 2020 - search.proquest.com
Increasing age, lower body mass index, a history of minor bleeding, concomitant antiplatelet
therapy with either clopidogrel+ aspirin or aspirin only, reduced renal function, and elevated …

[PDF][PDF] Prevalence and predictors of inappropriate apixaban dosing in patients with non‑valvular atrial fibrillation at a large tertiary academic medical institution

HA Badreldin, L Alreshoud, R Altoukhi, S Vasudevan… - 2019 - academia.edu
Objectives The aim of this study was to assess apixaban prescribing practices for stroke
prevention in patients with nonvalvular atrial fibrillation (NVAF), and to examine the factors …

Correction to: Prevalence and predictors of inappropriate apixaban dosing in patients with non‑valvular atrial fibrillation at a large tertiary academic medical institution

HA Badreldin, L Alreshoud, R Altoukhi… - Drugs & Therapy …, 2020 - academia.edu
Correction to: Prevalence and predictors of inappropriate apixaban dosing in patients with
non‑valvular atrial fibrillatio Page 1 Vol.:(0123456789) Drugs & Therapy Perspectives https://doi.org/10.1007/s40267-022-00959-x …